The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Regular medical monitoring ensures the effectiveness of PrEP, with minimal side effects for most users. Additionally, HIV-positive individuals can benefit from treatment as prevention (TasP).

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

Share on Pinterest Yeztugo is a twice-yearly injection to prevent HIV that could improve adherence rates compared to other PrEP medications. d3sign/Getty Images The FDA has approved lenacapvir, a ...

A six-month HIV prevention shot achieved a 96% success rate in clinical trials, but accessibility and regulatory hurdles remain a challenge ...

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...

The key to HIV treatment as prevention is meds you’ll take daily. The regimen itself is called antiretroviral therapy, or ART. It’s ideal to start as soon as you’ve been diagnosed.

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

The Trump administration’s cuts to U.S. health agencies announced Tuesday will reduce HIV prevention services and hamper Georgia’s efforts to tackle stubbornly high rates of new infection ...

A CDC webpage says that in the 2023 fiscal year, Congress appropriated roughly $1.3 billion for the CDC’s HIV, viral hepatitis, STD and tuberculosis prevention budget.